View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AB50 | Publication ID: Fall 2023 |
Title: Amendments to the Drug Enforcement Administration Hearing Regulations | |
Abstract:
This rule proposes to amend the Drug Enforcement Administration (DEA) hearing regulations that govern the procedures in administrative hearings to deny, revoke, or suspend a DEA registration to handle controlled substances or listed chemicals. |
|
Agency: Department of Justice(DOJ) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 1300 and 1301 21 CFR 1303 21 CFR 1308 and 1309 21 CFR 1312 and 1313 21 CFR 1315 and 1316 21 CFR 1321 | |
Legal Authority: 21 U.S.C. 875 to 877 |
Legal Deadline:
None |
||||||
Timetable:
|
Additional Information: DEA Docket number 395 | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Information URL: DPW@dea.gov | Public Comment URL: www.regulations.gov |
RIN Data Printed in the FR: No | |
Agency Contact: Scott A. Brinks Section Chief, Regulatory Drafting and Support Section, Diversion Control Division Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Springfield, VA 22152 Phone:571 362-8209 Email: scott.a.brinks@dea.gov |